Nothofagin
CAS: 11023-94-2
Ref. 3D-FN167471
| 1mg | 289.00 € | ||
| 2mg | 462.00 € | ||
| 5mg | 604.00 € | ||
| 10mg | 1,016.00 € | ||
| 25mg | 1,752.00 € |
Product Information
- 1-(3-beta-D-Glucopyranosyl-2,4,6-trihydroxyphenyl)-3-(4-hydroxyphenyl)-1-propanone
- 1-(3-β-<span class="text-smallcaps">D</span>-Glucopyranosyl-2,4,6-trihydroxyphenyl)-3-(4-hydroxyphenyl)-1-propanone
- 1-Propanone, 1-(3-β-<span class="text-smallcaps">D</span>-glucopyranosyl-2,4,6-trihydroxyphenyl)-3-(4-hydroxyphenyl)-
- 3′-Glucosylphloretin
- Nothofagin(8CI)
Nothofagin is a bioactive phenolic compound that has been found to have clinical relevance in the treatment of prostate cancer. The enzyme activities of aspalathin, which can be converted into nothofagin, have been shown to inhibit prostate cancer cells. In addition, nothofagin has been shown to inhibit the proliferation of sodium-dependent glucose transporter 1 (SGLT1) and the activity of liver cells. The protocatechuic acid in honeybush tea can be converted into nothofagin by hydrolysis with glycosidases. Nothofagin also inhibits basophilic leukemia by inhibiting DNA synthesis. It is believed that this inhibition may be due to its hydroxyl group and glycosidic bond.
Chemical properties
Technical inquiry about: 3D-FN167471 Nothofagin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
